Anglo French Drugs & Industries Share Price
PHYSICAL
PUBLIC LIMITED
Price Chart
1W
1M
1Y
MAX
High
₹3,168
Low
₹605
Return
36.27%
Buy Sell Anglo French Drugs & Industries Unlisted Shares
As of September 06, 2026, Anglo French Drug & Industries, Unlisted Shares are trading at ₹1,097.00 per share and face value is ₹10.00/share, with a 52-week high of ₹2,470.00 and 52-week low of ₹1,097.00. The minimun lot size is 120 shares, and the shares are traded on NSDL and CDSL.
ISIN
INE570E01016
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
12,91,000
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
141.62 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Profit After Tax
-12.34 Cr
It is the final profit left over after subtracting all operating and non operating items from net revenue.
Total Revenue
95.2 Cr
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
P/E
-11.48
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
P/B
1.25
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Listed on Small Exchange
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
-0.06 Cr
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
About Anglo French Drugs & Industries
- Anglo French Drugs & Industries Ltd. ("AFDIL" or "The company"), is primarily involved in the manufacturing of pharmaceutical formulation, which primarily involves mixing various chemical compounds into active drugs/ingredients. The company is the formulator, supplier, and distributor of drugs and medicines across nutraceuticals, CNS, skin, and respiratory segments.
- From being an importer of medicines in 1923, the company has emerged as the manufacturer, marketer, and distributor of over 350 products across the world; over a period of 100 years.
- AFDIL currently has the following divisions: AFD Pharma, Hospicare, Optima, Trading, and Export. AFD Pharma focuses on products for wellness and immunity, for the aging population; Hospicare products are focused on orthopedic doctors and general health; Optima division ensures the optimal supply of AFD's medicines; Trading division ensures the supply of raw materials to pharma. manufacturers; Export division focuses on AFDIL's export operations.
- The company's product portfolio involves the manufacturing of vitamins, anti-epileptics, anti-oxidants, sleep-inducing agents, cold and cough preparations, protein food supplements, digestive enzymes, and calcium supplements.
- AFDIL is India's first pharmaceutical company to manufacture single vitamin injections and a combination of B-complex Vitamins.
- AFDIL has announced the release of a new product called AFD-NP for the treatment of neuropathic pain, which has received approval from the Drug Control Department. The company has also ventured into 2 new categories: Respiratory Care, and Fertility space; by launching products in these segments.
- AFDIL initiated its exports in 1997 and currently has its presence in 16 countries across Eastern Europe, South East Asia, and Africa.
- During the year 2021-2022, the Company sold a portfolio of their brands to Lupin Ltd for a lump-sum consideration of approximately 305 crores. The consideration received will be utilized in different ways: development of new markets; development of new products; marketing in new countries; marketing to more and different institutions; new avenues of business such as rural sales and digital marketing; and investment
- The company was incorporated in 1923 and has its registered office in Bengaluru, Karnataka.
- The company is listed on Metropolitan Stock Exchange of India (MSEI), but it has not been traded on MSEI for the last 3 financial years. The last traded price is Rs 145.50
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Anglo French Drugs & Industries Media
News
Articles
Videos
Anglo-French Drugs & Industries reports standalone net loss of Rs 0.44 crore in the March 2025 quarter
02 May 2025
• Business Standard
Anglo-French Drugs & Industries reports standalone net profit of Rs 3.10 crore in the March 2024 quarter
30 May 2024
• Business Standard
Anglo-French Drugs & Industries reports standalone net loss of Rs 3.35 crore in the December 2023 quarter
14 Feb 2024
• Business Standard
Frequently Asked Question (FAQs)
Where can I find the annual report of Anglo French Drugs & Industries Ltd?
The annual report of Anglo French Drugs & Industries Ltd is available in the annual report section.
How to buy Anglo French Drugs & Industries Unlisted Shares?
Please find below the procedure for buying Anglo French Drugs & Industries Unlisted Shares at Planify.
• 1. You confirm booking of Anglo French Drugs & Industries Unlisted Shares with us at a trading price.
• 2. You provide your client master report (ask the broker if not available) along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
• 3. We will provide the bank details.
• 4. You need to transfer funds in that account.
• 5. Payment has to be done in RTGS/NEFT/IMPS CHEQUE TRANSFER. No CASH DEPOSIT.
• 6. Payment has to be done from the same account in which shares are to be credited.
• 7. We will transfer the shares in 24 hours if funds are credited before 2 pm.
Important Note: Please note that the lock-in period for selling Anglo French Drugs & Industries Unlisted Shares is 6 months after listing. Hence you can’t sell Anglo French Drugs & Industries Unlisted Shares which you bought in Pre-IPO for 6 months after its listing. i.e. You can sell it only after 6 months calculated from the listing date.
What is the lock-in period of Anglo French Drugs & Industries Unlisted Shares?
Lock-in period of Anglo French Drugs & Industries Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of Anglo French Drugs & Industries Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of Anglo French Drugs & Industries Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.
See More
Anglo French Drugs & Industries
₹ 1,097
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
MiQB, Plot 23, Sector 18, Maruti Industrial Development Area, Opposite VLCC corporate office, Gurugram, Haryana 122015
SEBI Registration
Mutual Fund License No.
ARN-164419
IRDA Code (1):
ABLIC1003123454
Startup India Certificate No.
DIPP93786
IRDA Code (2):
ABLIC1003131639
Licensed By
Stay Connected With Us
through our iOS and Android apps for an on-the-go investing experience. Download our apps today App Store or Google Play Store.
ⓒ 2016-2026 Planify. All rights reserved, Built with ❤️ in India